|
PF-55602 |
KETOROLACO TROMETAMINA Med Pharma 20 mg Cápsula de gelatina suave |
2023-08-07 |
|
Med Pharma |
Guatemala
|
Med Pharma |
Servicio De Comercio Internacional |
Selectpharma |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55603 |
KETOROLACO TROMETAMINA Selectpharma 20 mg Cápsula de gelatina suave |
2023-08-07 |
|
Med Pharma |
Guatemala
|
Med Pharma |
Servicio De Comercio Internacional |
Selectpharma |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55885 |
FIXAR 100 mg/5 mL Polvo para suspensión oral |
2023-10-02 |
|
Industria Farmacéutica |
Guatemala
|
Industria Farmacéutica |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55586 |
ETOFLAM 120 mg Tabletas recubiertas |
2023-08-03 |
|
Med Pharma |
Guatemala
|
Med Pharma |
Servicio De Comercio Internacional |
Selectpharma |
La Botica |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55588 |
TERAZOSINA Med Pharma 2 mg Tableta |
2023-08-03 |
|
Med Pharma |
Guatemala
|
Med Pharma |
Servicio De Comercio Internacional |
Selectpharma |
La Botica |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55614 |
MEBEVERINA CLORHIDRATO Med Pharma 200 mg Capsula de liberación prolongada |
2023-08-09 |
|
Med Pharma |
Guatemala
|
Med Pharma |
Servicio De Comercio Internacional |
Selectpharma |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55592 |
CLOTRIMAZOL Belsa 1% crema tópica |
2023-08-06 |
|
Droguería Belsa |
Guatemala
|
Droguería Belsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55595 |
ALBENDAZOL Belsa 200 mg/5mL Suspensión Oral |
2023-08-06 |
|
Droguería Belsa |
Guatemala
|
Droguería Belsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55845 |
VITAMINAS NEUROTROPAS Infasa 25,000 Solución Inyectable |
2023-09-24 |
|
Industria Farmacéutica |
Guatemala
|
Industria Farmacéutica |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55601 |
TERAZOSINA Med Pharma 5 mg Tableta |
2023-08-07 |
|
Med Pharma |
Guatemala
|
Med Pharma |
Servicio De Comercio Internacional |
Selectpharma |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|